2009
DOI: 10.1093/jac/dkp065
|View full text |Cite
|
Sign up to set email alerts
|

Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

Abstract: These evidence-based guidelines are an updated version of those published in 2006. They have been produced after a literature review of the treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA). The guidelines aim to complement those recently published for the antibiotic treatment of common and emerging community-onset MRSA infections in the UK. The guidelines have reviewed and updated, where appropriate, previous recommendations, taking into account any changes in the UK epidemiology… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
90
0
3

Year Published

2010
2010
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 143 publications
(94 citation statements)
references
References 120 publications
1
90
0
3
Order By: Relevance
“…Inappropriate antimicrobial therapy leads to increased healthcare associated costs, prolonged hospital stay and even increased mortality rates [12,13). Current International and United Kingdom guidelines recommend a minimum of 14 days treatment for uncomplicated bacteraemia and longer treatment such as 4-6 weeks in deep seated infections three [9][10][11]. These recommendations help to reduce relapse.…”
Section: Discussionmentioning
confidence: 99%
“…Inappropriate antimicrobial therapy leads to increased healthcare associated costs, prolonged hospital stay and even increased mortality rates [12,13). Current International and United Kingdom guidelines recommend a minimum of 14 days treatment for uncomplicated bacteraemia and longer treatment such as 4-6 weeks in deep seated infections three [9][10][11]. These recommendations help to reduce relapse.…”
Section: Discussionmentioning
confidence: 99%
“…R ecently published guidelines have recommended the use of vancomycin in the management of severe MRSA infection [29] , but it was reported that the vancomycin resistant S. aureus was emerging in northern India [10] . So that the search of novel anti-MRSA molecules is needed globally.…”
Section: Discussionmentioning
confidence: 99%
“…Se debe completar dicho tratamiento con la utilización de solución jabonosa de Digluconato de Clorhexidina al 4% para el aseo diario del paciente (debe considerarse la posibilidad de reacciones cutáneas adversas), incidiendo en pliegues (ingles y axilas) y lavado de cabello al menos una vez a la semana [18][19][20][21] .…”
Section: Tratamiento De Pacientes Infectados/colonizados Por Sarmunclassified